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Abstract: The aim of the present study was to estimate the prevalence of rheumatoid arthritis in the southern part of 
Denmark. Using a screening questionnaire, telephone interview, register data, and a clinical examination cases were 
ascertained from a random sample of 4995 individuals over the age of 15. As case definition we used the original and 
modified 1987 American College of Rheumatology classification criteria. The overall point prevalence was 0.26% (95% 
confidence interval: 0.13-0.39) in the total sample and 0.35% (95% confidence interval: 0.17-0.52) among the responders; 
the cumulative prevalence was 0.75% (95% confidence interval: 0.52-0.97) in the total sample and 0.92% (95% 
confidence interval: 0.62-1.21) among the responders. 
The cumulative prevalence was higher than in other studies combining the results of a survey with register data. The point 
prevalence was underestimated due to low participation rate in the clinical examination and remission among the 
participants. 
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INTRODUCTION 
  In most populations of European origin, the overall 
prevalence of rheumatoid arthritis (RA) is 0.5% to 1% [1]. 
Only a few studies have investigated whether the prevalence 
of RA has changed over time but some reports from 
populations of different origin have indicated that the 
prevalence may be decreasing [2-6]. 
  In Denmark, the point prevalence of RA has previously 
been estimated in two studies. In a nationwide sample from 
the 1960s, the overall point prevalence of probable, definite 
and classic RA according to the Rome criteria was 0.85% 
[7]. In a study from the Faroe Islands in the North Atlantic 
Ocean in the 1980s, in the age group between 40 and 74 
years the point prevalence according to the 1987 American 
College of Rheumatology (ACR) criteria was 1.1% [8]. 
There is some evidence that a high dietary intake of oil-rich 
fish protects against the development of RA [9] and a small 
study from an isolated, fish-eating community, like the Faroe 
Islands, may not give relevant nor precise estimates of RA in 
the total Danish population. Moreover, data on the 
prevalence of RA may be used for the planning of health-
care provision and current estimates are therefore essential. 
  In the present study we report the point prevalence and 
the cumulative prevalence of RA [10] in a random sample of 
the population in the southern part of Denmark in 2004. For 
the ascertainment of cases we used a screening mail 
questionnaire, telephone interview, register data, and a 
clinical examination. 
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MATERIALS AND METHODOLOGY 
Setting and Sample Size 
  Using a unique identification number (CPR-number) 
given to all Danish citizens by an office under the 
Department of the Interior, a random sample of 5000 
individuals over the age of 15 was drawn from the County of 
South Jutland (Fig. 1). With a 60% response rate, 3% of the 
responders self-reporting RA and 20% in whom RA would 
be ascertained at a clinical examination, we expected an 
overall point prevalence of 0.6% (95% confidence interval 
(CI): 0.4-1.0). 
 
Fig. (1). The County of South Jutland, a region in the southern part 
of Denmark with a 2004 population of 203,799 individuals over the 
age of 15. 
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Screening Mail Questionnaire 
  The screening mail questionnaire consisted of five items: 
1) “Have you or have you ever had RA”; 2) “Have you or 
have you ever had more than two swollen joints at the same 
time”; 3) “Have you or have you ever had joint stiffness 
lasting more than one hour in the morning”; 4) “Have you 
ever been diagnosed as having RA by a doctor”; 5) “Have 
you ever been examined or treated for RA by a doctor”. 
Additionally, it was possible to write a short message on the 
questionnaire. We sent out one reminder including the 
questionnaire and a stamped, pre-addressed return envelope. 
  The items in the questionnaire were selected by the 
authors and evaluated for face validity by a group of 
rheumatologists and a linguist. In pilot test with patients 
from a rheumatology hospital self-administration of the 
questionnaire was observed by a research nurse and found to 
be feasible. In 67 individuals (29 patients with RA, 18 with  
other rheumatic diseases, 20 healthy individuals 
(employees)) recruited from the same setting the sensitivity 
and specificity of the first item on the questionnaire was 1.00 
(95% CI: 0.88-1.00) and 0.82 (95% CI: 0.66-0.92), 
respectively. Answering “yes” to all five items the sensitivity 
was 0.79 (95% CI: 0.60-0.92) and specificity 0.90 (95% CI: 
0.75- 0.97). Using Cohen’s kappa [11] in a test-retest study 
in 53 individuals with a time interval of six weeks the 
agreement for the first item was 1.00 (95% CI: 1.00-1.00) 
and for all five items it was 0.91 (95% CI: 0.80-1.00). 
Register Data 
  Using the CPR-numbers individuals from the sample 
were identified in nationwide and local registers. Medical 
records or questionnaire data were subsequently scrutinized 
to ascertain cases that cumulatively fulfilled the 1987 ACR 
classification criteria [12]. 
  Danish National Hospital Register (DNHR): The DNHR 
is a nationwide register with administrative data on in- and 
outpatients from Danish hospitals and the register may be 
used for epidemiological research. In the DNHR the 
diagnoses at the discharge of a patient are registered 
according to the International Classification of Diseases 
(ICD) [13]. In the present study all individuals from the 
sample with positive RA diagnoses in the DNHR from 1978 
to 2003 (ICD-8 codes 712.* and ICD-10 codes M05.0-
M05.9 and M06.0-M06.9) were identified and copies of 
medical records from relevant admissions were requested 
from the hospitals. 
  The King Christian X Hospital for Rheumatic Diseases: 
At the time of the study the rheumatology hospital served as 
a referral centre for patients with rheumatic diseases from the 
County of South Jutland. In Denmark hospitals are required 
to maintain medical records for ten years after the last 
contact with a patient, but at the rheumatology hospital 
historical medical records are, as a rule of thumb, not 
destroyed. At the rheumatology hospital we expected to be 
able to identify patients with RA using data from the DNHR. 
However, the DNHR does not include data before 1978, data 
on outpatients with RA from the rheumatology hospital that 
had not been discharged at the time of the present study, or 
patients that might have been misclassified at discharge. 
Therefore, the hospital register was searched by hand for 
medical records on individuals from the sample who 
answered “yes” to the first item on the screening mail 
questionnaire (i.e. self-reported RA), wrote a message on the 
questionnaire indicating that they could have RA, or had 
positive RA diagnoses in the DNHR. 
  The Public Health Insurance:  In Denmark, the total 
population is covered by the Public Health Insurance. Private 
practising rheumatologists are reimbursed by the Health 
Insurance if their patients are treated with disease-modifying 
anti-rheumatic drugs (DMARDs). As far as we know, the 
accuracy of data from the Public Health Insurance has not 
been evaluated. We were given access to Health Insurance 
data from 1997 to 2004 to identify individuals from the 
sample treated with DMARDs by private practising 
rheumatologists. The rheumatologists would then be asked 
by questionnaire to document if the 1987 ACR list criteria 
had been fulfilled. 
  General practice: If informed consent was given at the 
clinical examination and the classification criteria for RA 
had not been fulfilled, general practitioners (GPs) were 
asked by questionnaire to document if the 1987 ACR list 
criteria had been fulfilled. 
Clinical Examination 
  The responders to the mail questionnaire were invited to 
attend for a clinical examination at the rheumatology 
hospital in the following ways: A. Directly, if they: 1) 
answered “yes” to all five items on the questionnaire and did 
not make any comments that, judged by one of the 
investigators (JKP), contradicted that they could have RA; 2) 
did not answer “yes” to all items, but wrote a message on the 
questionnaire that, judged by one of the investigators (JKP), 
was conceived as being a strong indicator of RA; 3) were 
registered with RA diagnoses in the DNHR. B. After a 
telephone interview carried out in the responders who 
answered “yes” to the first item on the questionnaire and had 
not been invited directly. 
  In the telephone interview the individuals were asked 
when the first symptoms of RA appeared, to indicate which 
joint areas that were affected, if the involvement of joints 
was symmetrical, if they currently had joint swelling or 
deformities, if they had ever had a positive test for 
rheumatoid factors or radiographs taken that indicated RA, if 
they had ever been diagnosed with other rheumatic diseases 
than RA, and if drugs for RA had ever been prescribed by a 
doctor. The individuals who at the telephone interview were 
judged by the interviewer (JKP) to be potential RA cases 
were invited to the examination. 
  At the rheumatology hospital the individuals were 
examined by one of five rheumatologists who all were 
trained joint assessors. If two or three criteria of the modified 
1987 ACR list format [14] were fulfilled, a test for IgM 
rheumatoid factors (Enzyme-Linked Immunosorbent Assay, 
cut-off: 8 IU/ml) and radiographs of hands and feet were 
carried out. The modified 1987 ACR criteria include both 
malalignment and joint swellings as signs of RA. 
Accordingly, the modified 1987 ACR criteria identifies both 
individuals with signs of current and previously active RA 
and in a previous survey the modified criteria were more 
sensitive than the 1987 ACR criteria for ascertaining RA 
cases [14]. Prevalence of Rheumatoid Arthritis in the Southern Part of Denmark  The Open Rheumatology Journal, 2011, Volume 5   93 
Statistics and Ethics 
  When calculating the cumulative prevalence, individuals 
who fulfilled the modified 1987 ACR criteria at the 
examination, or had previously fulfilled the 1987 ACR 
criteria documented in medical records or by questionnaire, 
were counted as ever RA cases. When calculating the point 
prevalence, individuals who satisfied the modified 1987 
ACR criteria at the examination were counted as cases. 
Using the direct method, the prevalence estimates were 
adjusted for age and sex to the 2004 Danish population and 
reported with 95% CI. Population data were provided by 
Statistics Denmark. Statistics were done using Stata, version 
8.2. 
  The study was approved by the local ethics committee 
(reference no. 2426-02) and the Danish Data Protection 
Agency (reference no. 2002-41-2231). 
RESULTS 
Response Rate and Register Data 
  The screening questionnaire was send to 5000 individual 
but the addresses of five individuals were unknown and the 
effective sample size was 4995 (Fig. 2). Overall, 68% 
returned the questionnaire and the response rate was highest 
among the elderly (Table 1). Among the non-responders the 
mean age was 45 years and 45% were females, among the 
responders the mean age was 52 years and 55% were 
females. 
  A total of 278 individuals self-reported RA by answering 
yes to the first item on the screening questionnaire, or had 
RA diagnoses in the DNHR, or made comments in the 
questionnaire indicating that they could have RA. Medical 
records or questionnaire data from hospitals and GPs were 
available in 110 individuals. According to the Public Health 
Insurance no individuals from the sample had been treated 
with DMARDs by private practising rheumatologists from 
1997 to 2004. 
Cases Ascertained 
  Among the non-responders (group A, Fig. 2), six 
individuals had RA diagnoses in the DNHR and four had 
ever RA. No individuals from group A were examined. In the 
group of responders who did not self-report RA (group B, 
Fig. 2), four individuals made comments indicating RA but 
one did not want to attend for the examination. Five were 
registered in the DNHR. One individual, who was registered 
in the DNHR also made comments indicating RA. 
  Eighty-one individuals who self-reported RA (group C, 
Fig. 2) were not eligible for the clinical examination (67 did 
not want to attend, eight could not be reached by phone to 
arrange the examination or to carry out the telephone 
interview, six questionnaires had been handed over to and 
returned by individuals not in the sample) and 14 had ever 
RA. A subgroup of 30 individuals answered “yes” to all 
items and seven were ever RA cases. 
  Out of the remaining 182 individuals who self-reported 
RA (group D, Fig. 2), 125 were interviewed by phone and 
eight were invited for the examination. Fifty-seven 
individuals were invited directly for the examination (48 
answered “yes” to all five items, nine with positive 
diagnoses in the DNHR). A subgroup of 55 individuals 
answered “yes” to all items but when contacted to plan the 
examination, seven made comments that made RA less 
likely and they were not invited after the telephone 
interview. 
 
 
RA: rheumatoid arthritis. Self-reported RA: Individuals answering “yes” to the first item on screening mail questionnaire (“Have you or have you ever had 
rheumatoid arthritis”). Case definitions: Ever RA, fulfilment of the 1987 American College of Rheumatology (ACR) criteria documented in medical records or 
by questionnaire or fulfilment of the modified 1987 ACR criteria at examination; Modified 1987 ACR, fulfilment of the modified 1987 ACR criteria at 
examination. 
Fig. (2). Response to screening questionnaire, selection for clinical examination, and numbers of cases ascertained in a sample of the 
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  A total of 73 individuals were examined and 24 had ever 
RA (group E, Fig. 2), one individual came from group B and 
23 from group D. Nineteen ever RA cases (79%) were 
currently treated with DMARDs. On the day of the   
examination, 15 individuals fulfilled the modified 1987 ACR 
criteria. 
Prevalence 
  Among the responders a total of 38 ever RA cases were 
identified and the cumulative prevalence 0.92% (Table 1). In 
the total sample 42 cases were identified and the cumulative 
prevalence was 0.75%. Using the modified 1987 ACR 
criteria, the point prevalence was 0.35% among the 
responders and 0.26% in the total sample. The prevalence 
was highest among women and the elderly. 
DISCUSSION 
  Using an extensive ascertainment procedure, we have 
provided updated estimates of the prevalence of RA in 
Denmark. 
  After one reminder the overall response rate to the 
screening mail questionnaire was 68%. This is similar to 
other studies combining the results of a survey with register 
data where response rates have been 49% to 74% [15-18]. 
Using up to three reminders may lead to a higher response 
rate [3]. 
  Some comments on the approach used for selecting 
individuals for the clinical examination are needed. In 
previous studies RA has only been ascertained in about one 
in five individuals who self-report RA in an interview or a 
questionnaire [19-22]. Instead of examining every individual 
who self-reported RA we used a telephone interview to 
exclude a subgroup of responders in whom we expected it to 
be impossible to ascertain the fulfilment of the classification 
criteria at a clinical examination. Recently, a standardized 
telephone interview conducted by laypeople has been 
described as a valid method to identify individuals with RA 
from a survey [23]. In our study, the decision on who was 
invited for the clinical examination was made by a physician 
and it was not based on a pre-defined, validated algorithm. 
Table 1.  Response Rate, Crude and Adjusted* Point Prevalence and Cumulative Prevalence of Rheumatoid Arthritis According to 
Age and Sex in a Random Sample of the Population in the Southern Part of Denmark (95% Confidence Interval) 
 
Females  Males  Females and Males   
15-59 60+  All 15-59 60+  All 15-59 60+  All 
Response  rate,  %  70 76 72 58 77 64 64 77  68 
Prevalence, responders             
Responders,  n  1235 642 1877 993  532 1525  2228  1174  3402 
Modified  1987  ACR,  n  3 7  10  0 5 5 3  12  15 
Point prevalence, %  0.24 
(0.05-0.71) 
1.09 
(0.44-2.23) 
0.53 
(0.26-0.98)  
0 
(0.00-0.37) 
0.94 
(0.31-2.18) 
0.33 
(0.11-0.76) 
0.14 
(0.03-0.39) 
1.02 
(0.53-1.78) 
0.44 
(0.25-0.73) 
Adjusted point  
prevalence, % 
   0.46 
(0.17-0.74) 
   0.24 
(0.03-0.44) 
   0.35 
(0.17-0.52) 
Ever RA,  n  10  17 27 1 10  11  11  27  38 
Cumulative 
 prevalence, % 
0.81 
(0.39-1.48) 
2.65 
(1.55-4.21) 
1.44 
(0.95-2.10) 
0.10 
(0.00-0.56) 
1.88 
(0.91-3.43) 
0.72 
(0.36-1.29) 
0.49 
(0.25-0.88) 
2.30 
(1.52-3.33) 
1.12 
(0.79-1.53) 
Adjusted cumulative  
prevalence, % 
   1.27 
(0.79-1.76) 
   0.55 
(0.22-0.79) 
   0.92 
(0.62-1.21) 
Prevalence, total sample            
Total sample, n  1757  840  2597  1709  689  2398  3466  1529  4995 
Modified  1987  ACR,  n  3 7  10  0 5 5 3  12  15 
Point prevalence, %  0.17 
(0.04-0.50) 
0.83 
(0.34-1.71) 
0.39 
(0.19-0.71) 
0 
(0.00-0.22) 
0.73 
(0.24-1.69) 
0.21 
(0.07-0.49) 
0.09 
(0.02-0.25) 
0.79 
(0.41-1.37) 
0.30 
(0.17-0.50) 
Adjusted point 
 prevalence, % 
   0.34 
(0.13-0.55) 
   0.18 
(0.02-0.34) 
   0.26 
(0.13-0.39) 
Ever RA,  n  10  21 31 1 10  11  11  31  42 
Cumulative  
prevalence, % 
0.57 
(0.27-1.05)  
2.50 
(1.55-3.80) 
1.19 
(0.81-1.69) 
0.06 
(0.00-0.33) 
1.45 
(0.70-2.65) 
0.46 
(0.23-0.82) 
0.32 
(0.16-0.57) 
2.03 
(1.38-2.87) 
0.84 
(0.61-1.14) 
Adjusted cumulative  
prevalence, % 
   1.06 
(0.68-1.43) 
   0.41 
(0.17-0.65) 
   0.75 
(0.52-0.97) 
Adjusted for age or age and sex to the 2004 Danish population using the direct method. Case definitions: Modified 1987 ACR, fulfilment of the modified 1987 American College 
of Rheumatology (ACR) criteria for rheumatoid arthritis at examination. Ever RA fulfilment of the 1987 ACR criteria documented in medical records or by questionnaire or 
fulfilment of the modified 1987 ACR criteria at examination. Prevalence of Rheumatoid Arthritis in the Southern Part of Denmark  The Open Rheumatology Journal, 2011, Volume 5   95 
When making the decision the physician probably used all 
available sources of information, including intuition and his 
prior theoretical and clinical experience. Using this approach 
we probably excluded individuals who did not know that in 
the nomenclature used by physicians RA refers to a specific 
disease and not rheumatic symptoms in general. This is 
supported by the fact that no individuals excluded from the 
examination using this approach were ascertained as ever RA 
cases using register data. 
  The results of the pilot study evaluating the performance 
of the questionnaire suggested that using a specific test (i.e. 
all five items on the questionnaire) for screening, some false 
positive results were still to be expected. Accordingly, 
instead of being examined seven individuals who answered 
“yes” to all five items on the questionnaire were telephone 
interviewed because they made comments that made RA 
seem less likely. For instance, one individual indicated that 
the only symptom of RA was low back pain after an 
accident. None of these seven individuals were ascertained 
as ever RA cases using register data. 
  The responders could write a short message on the 
screening questionnaire. Only a few messages were judged 
as being strong indicators of RA but one individual (from 
group B, Fig. 2 ) who used this option was ascertained as 
having  ever RA. However, the same individual was also 
registered in the DNHR and in our study the sensitivity of 
the screening procedure was not improved by allowing an 
informal message to be included on the questionnaire. 
  In a sensitivity analysis of the estimates of the cumulative 
prevalence the most extreme scenario would be that all non-
responders to the screening questionnaire (group A, Fig. 2) 
were ever RA cases. In our study, however, a more plausible 
estimate is generated by assuming that the fraction of 
individuals with RA among the non-responders was the same 
as among the responders. In this scenario there would have 
been a total of 18 ever RA cases (0.0112*159318) among 
the non-responders. We actually identified four ever RA 
cases among the non-responders using the DNHR and this 
underlines that the DNHR may be a useful tool in 
epidemiological research [24]. Among the non-responders 
the mean age and the fraction of females were lower than 
among the responders. Since the prevalence of RA increases 
with age in most age groups and female preponderance is 
typical [3], it is less likely that we may have missed several 
cases among the non-responders. 
  From the medical records it appeared that one individual 
with  ever RA had been diagnosed as having juvenile 
idiopathic arthritis and one as having psoriatic arthritis. 
However, the classification criteria used in our study are 
without exclusion criteria and both were included as cases. 
  Using the original or modified 1987 ACR criteria the 
overall cumulative prevalence has been estimated in four 
studies combining the results of a survey with register data 
[15-18]. In Dublin, Ireland, the prevalence was 0.49% [15] 
and in Halland, Sweden, it was 0.51% [16]. In Oslo, 
Norway, the prevalence was 0.44% [17] and in Chiavari, 
Italy, it was 0.36% [18]. By sampling telephone numbers and 
conducting telephone interviews the cumulative prevalence 
of RA in France was 0.31% [25] and in Lithuania it was 
0.55% [26]. In Rochester, Minnesota, detailed medical data 
are collected systematically from health care facilities 
serving the community and in 2007 the cumulative 
prevalence of RA was 0.72% [27]. In our study we identified 
ever RA cases among the responders and the non-responders 
and we therefore believe that the most reasonable estimate of 
the cumulative prevalence of RA was between 0.75% and 
0.92%. 
  The comparison of prevalence estimates from different 
populations and time periods may be hampered for various 
reasons. For instance, RA is an inflammatory disease with 
episodic activity and individuals with RA may have different 
symptoms and knowledge about the disease according to 
disease severity. This makes it inherently difficult to 
measure the prevalence of RA using a short screening 
questionnaire that may not cover the many factors associated 
with the varying phenotype of RA. However, the 
discrepancy in prevalence estimates between our study and 
other populations using the results of a survey combined 
with register data [15-18] may reflect differences in 
completeness of registrations [28], quality of coding, and the 
accuracy of clinical diagnoses [29]. 
  Turning to the estimates of the point prevalence, a total 
of 18 individuals were ascertained as ever RA cases using 
register data, but they did not return the questionnaire nor 
wanted to participate in the clinical examination (group A 
and C, Fig. 2). Most of them were outpatients at the 
rheumatology hospital and when invited they indicated that 
they did not have time for an additional examination at the 
hospital. If we assume that the 18 ever RA case had all been 
responders and the same proportion as in group E (Fig. 2) 
would have satisfied the modified 1987 ACR criteria if 
examined, a total of 11 cases would have been missed 
(15/24*1811). Moreover, the modified 1987 criteria were 
not fulfilled in four ever RA cases at the clinical 
examination, probably due to drug induced remission. Thus, 
in the present study the point prevalence was most likely 
underestimated because of low participation rate in the 
clinical examination and drug induced remission. Examining 
individuals in their homes may lead to a higher participation 
rate [3]. 
  In other recent studies [3, 30-36], the overall point 
prevalence of RA has ranged from 0.38% [30] to 0.67% 
[36]. 
  In the 1960s the point prevalence of RA (probable, 
classic, and definite RA) was 0.85% in a nationwide random 
sample of the Danish population. As case definition 
Sørensen used the Rome criteria for active and inactive RA 
[7]. When comparing the adjusted point prevalence from the 
present study with the results of the study by Sørensen, the 
occurrence of RA in Denmark may have decreased over the 
last four decades (Table 2). The highest decrease seems to 
have occurred in females, which is in line with other studies. 
A decrease in the point prevalence of RA has been observed 
in females from the UK between the 1950s and 1990 [2] and 
the 1950s and 2000 [3], perhaps caused by the introduction 
of the oral contraceptive pill [2, 3]. A decrease has also been 
observed in female Pima Indians between 1965 and 1990 [5], 
and a decrease has been suggested in a Japanese population 
from 1965 to 1996 [4]. 96   The Open Rheumatology Journal, 2011, Volume 5  Pedersen et al. 
  In the study by Sørensen individuals with probable RA 
according to the Rome criteria were included as cases [7], 
but they would probably not fulfil the modified 1987 ACR 
criteria used in the present study. Moreover, in our study the 
point prevalence was most likely underestimated. Taking 
these biases into account a true secular decline in the 
prevalence of RA in Denmark seems less convincing. 
CONCLUSION 
  Using an extensive ascertainment procedure we have 
provided updated estimates of the prevalence of RA in 
Denmark. The point prevalence of RA was most likely 
underestimated due to low participation rate and drug-
induced remission among the individuals who attended the 
clinical examination. However, the cumulative prevalence 
was higher than reported in other studies combining the 
results of a survey with register data. 
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